Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.

Saved in:

Bibliographic Details
Title:	Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.
Authors:	Kharfan-Dabaja, M A¹, Labopin, M², Bazarbachi, A³, Hamladji, R M⁴, Blaise, D⁵, Socié, G⁶, Lioure, B⁷, Bermudez, A⁸, Lopez-Corral, L⁹, Or, R¹⁰, Arcese, W¹¹, Fegueux, N¹², Nagler, A¹³, Mohty, M¹⁴
Source:	Bone Marrow Transplantation. Sep2014, Vol. 49 Issue 9, p1170-1175. 6p. 4 Charts, 2 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	02683369
DOI:	10.1038/bmt.2014.133